Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus

Hippocampus

Volumn 16, Issue 6, 2006, Pages 551-559

  Xu, Haiyun ^a,b   Chen, Zhong ^a,c   He, Jue ^a   Haimanot, Samson ^a   Li, Xiaokun ^b   Dyck, Lillian ^a   Li, Xin Min ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Antidepressants; Antipsychotics; BDNF; Cell proliferation; Hippocampus

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; QUETIAPINE; VENLAFAXINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL PROLIFERATION; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; HIPPOCAMPUS; IMMOBILIZATION STRESS; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RAT STRAIN; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL PROLIFERATION; CHRONIC DISEASE; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DIBENZOTHIAZEPINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HIPPOCAMPUS; NEURONAL PLASTICITY; NEURONS; RATS; RESTRAINT, PHYSICAL; SCHIZOPHRENIA; SEROTONIN UPTAKE INHIBITORS; STEM CELLS; STRESS, PSYCHOLOGICAL;

EID: 33745338513     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20184     Document Type: Article

References (78)

1. Aberg MA, Aberg ND, Palmer TD, Alborn AM, Carlsson-Skwirut C, Bang P, Rosengren LE, Olsson T, Gage FH, Eriksson PS. 2003. IGF-I has a direct proliferative effect in adult hippocampal progenitor cells. Mol Cell Neurosci 24:23-40.
2. Arvanitis LA, Miller BG. 1997. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry 42:233-246.
3. Aydemir O, Deveci A, Taneli F. 2005. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: A preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29:261-265.
4. Bai O, Chlan-Fourney J, Bowen R, Keegan D, Li XM. 2003. Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J Neurosci Res 71:127-131.
5. Bain MJ, Dwyer SM, Rusak B. 2004. Restraint stress affects hippocampal cell proliferation differently in rats and mice. Neurosci Lett 368:7-10.
6. Bjornebekk A, Mathe AA, Brene S. 2005. The antidepressant effect of running is associated with increased hippocampal cell proliferation. Int J Neuropsychopharmacol 8:357-368.
7. Borison RL, Arvanitis LA, Miller BG. 1996. ICI 204,636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group. J Clin Psychopharmacol 16:158-169.
8. Cameron HA, Gould E. 1994. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience 61:203-209.
9. Cameron HA, McKay RD. 2001. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J Comp Neurol 435: 406-417.
10. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. 2001. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50:260-265.
11. Chen Z, Xu H, Haimano S, Li X, Li XM. 2005. Quetiapine and venlafaxine synergically regulate heme oxygenase-2 protein expression in the hippocampus of stressed rats. Neurosci Lett 389:173-177.
12. Cohrs S, Pohlmann K, Guan Z, Jordan W, Meier A, Huether G, Ruther E, Rodenbeck A. 2004. Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects. Psychopharmacology 174: 414-420.
13. Connor B, Dragunow M. 1998. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev 27:1-39.
14. Denys D, van Megen H, Westenberg H. 2002. Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: An open-label study. J Clin Psychiatry 63:700-703.
15. Dinan T. 2001. Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis. Hum Psychopharmacol 16:89-93.
16. Ernfors P, Ibanez CF, Ebendal T, Olson L, Persson H. 1990. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: Developmental and topographical expression in the brain. Proc Natl Acad Sci USA 87:5454-5458.
17. Fumagalli F, Molteni R, Roceri M, Bedogni F, Santero R, Fossati C, Gennarelli M, Racagni G, Riva MA. 2003. Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity. J Neurosci Res 72: 622-628.
18. Fumagalli F, Molteni R, Bedogni F, Gennarelli M, Perez J, Racagni G, Riva MA. 2004. Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801. Neuroreport 15:2109-2112.
19. Goff DC, Midha KK, Sarid-Segal O, Hubbard JW, Amico E. 1995. A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia. Psychopharmacology 117:417-423.
20. Gould E, Woolley CS, McEwen BS. 1991. Naturally occurring cell death in the developing dentate gyrus of the rat. J Comp Neurol 304:408-418.
21. Gould E, Reeves AJ, Graziano MS, Gross CG. 1999. Neurogenesis in the neocortex of adult primates. Science 286:548-552.
22. Gutierrez MA, Stimmel GL, Aiso JY. 2003. Venlafaxine: A 2003 update. Clin Ther 25:2138-2154.
23. Hirose S, Ashby CR Jr. 2002. An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy. J Clin Psychiatry 63:733-736.
24. Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA. 1990. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 9:2459-2464.
25. Humpel C, Wetmore C, Olson L. 1993. Regulation of brain-derived neurotrophic factor messenger RNA, protein at the cellular level in pentylenetetrazol-induced epileptic seizures. Neuroscience 53:909-918.
26. Jiang W, Wan Q, Zhang ZJ, Wang WD, Huang YG, Rao ZR, Zhang X, 2003. Dentate granule cell neurogenesis after seizures induced by pentylenetrazol in rats. Brain Res 977:141-148.
27. Jiang W, Zhang Y, Xiao L, Van Cleemput J, Ji SP, Bai G, Zhang X. 2005. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest 115:3104-3116.
28. Khawaja X, Xu J, Liang JJ, Barrett JE. 2004. Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. J Neurosci Res 75:451-460.
29. Kleindienst A, McGinn MJ, Harvey HB, Colello RJ, Hamm RJ, Bullock MR. 2005. Enhanced hippocampal neurogenesis by intra-ventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury. J Neurotrauma 22:645-655.
30. Kodama M, Fujioka T, Duman RS. 2004. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry 56:570-580.
31. Lindefors N, Brodin E, Metsis M. 1995. Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience 65: 661-670.
32. Luo C, Xu H, Li XM. 2005. Quetiapine reverses the suppression of hippocampal neurogenesis caused by repeated restraint stress. Brain Res 1063:32-39.
33. Madhusoodanan S, Brenner R, Alcantra A. 2000. Clinical experience with quetiapine in elderly patients with psychotic disorders. J Geriatr Psychiatry Neurol 13:28-32.
34. Magarinos AM, McEwen BS. 1995. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 69: 89-98.
35. Malberg JE, Duman RS. 2003. Cell proliferation in adult hippocampus is decreased by inescapable stress: Reversal by fluoxetine treatment. Neuropsychopharmacology 28:1562-1571.
36. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. 2000. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-9010.
37. Ming GL, Song H. 2005. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 28:223-250.
38. Miyamoto S, Duncan GE, Marx CE, Lieberman JA. 2005. Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10:79-104.
39. Murakami S, Imbe H, Morikawa Y, Kubo C, Senba E. 2005. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci Res 53:129-139.
40. Nakagawa S, Kim JE, Lee R, Chen J, Fujioka T, Malberg J, Tsuji S, Duman RS. 2002. Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus. J Neurosci 22:9868-9876.
41. Nibuya M, Morinobu S, Duman RS. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547.
42. Nibuya M, Nestler EJ, Duman RS. 1996. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16:2365-2372.
43. Nikisch G, Mathe AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P. 2005. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: Relationship with S-citalopram concentrations in plasma and cerebro-spinal fluid (CSF) and clinical response. Psychopharmacology 181: 751-760.
44. Park C, Cho K, Ryu JH, Shin KS, Kim J, Ahn H, Huh Y. 2004. 7-Nitroindazole upregulates phosphorylated cAMP response element binding protein, polysialylated-neural cell adhesion molecule and tryptophan hydroxylase expression in the adult rat hippocampus. Brain Res 1008:120-125.
45. Paxinos G, Watson C. 1986. The Rat Brain in Stereotaxic Coordinates. London: Academic Press.
46. Pencea V, Bingaman KD, Wiegand SJ, Luskin MB. 2001. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci 21:6706-6017.
47. Purdon SE, Malla A, Labelle A, Lit W, 2001. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 26:137-149.
48. Radley JJ, Morrison JH. 2005. Repeated stress and structural plasticity in the brain. Ageing Res Rev 4:271-287.
49. Richelson E. 1999. Receptor pharmacology of neuroleptics: Relation to clinical effects. J Clin Psychiatry 60 (Suppl 10):5-14.
50. Rowe W, Steverman A, Walker M, Sharma S, Barden N, Seckl JR, Meaney MJ. 1997. Antidepressants restore hypothalamic-pituitary-adrenal feedback function in aged, cognitively-impaired rats. Neurobiol Aging 18:527-533.
51. Sajatovic M, Mullen JA, Sweitzer DE. 2002. Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis. J Clin Psychiatry 63:1156-1163.
52. Sax KW, Strakowski SM, Keck PE Jr. 1998. Attentional improvement following quetiapine fumarate treatment in schizophrenia. Schizophr Res 33:151-155.
53. Scaccianoce S, Del Bianco P, Caricasole A, Nicoletti F, Catalani A. 2003. Relationship between learning, stress and hippocampal brain-derived neurotrophic factor. Neuroscience 121:825-828.
54. Scharfman H, Goodman J, Macleod A, Phani S, Antonelli C, Croll S. 2005. Increased neurogenesis and the ectopic granule cells after intra-hippocampal BDNF infusion in adult rats. Exp Neurol 192:348-356.
55. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW, 1996. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 93:3908-3913.
56. Shors TJ. 2004. Memory traces of trace memories: Neurogenesis, synaptogenesis and awareness. Trends Neurosci 27:250-256.
57. Shors TJ, Miesegaes G, Beylin A, Zhao M, Rydel T, Gould E. 2001. Neurogenesis in the adult is involved in the formation of trace memories. Nature 410:372-376.
58. Siddiqui Z, Ramaswamy S, Petty F. 2005. Quetiapine therapy for corticosteroid-induced mania. Can J Psychiatry 50:77-78.
59. Silver H, Nassar A. 1992. Fluvoxamine improves negative symptoms in treated chronic schizophrenia: An add-on double-blind, placebo-controlled study. Biol Psychiatry 31:698-704.
60. Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG. 1997. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry 54:549-557.
61. Smith MA, Makino S, Kvetnansky P, Post RM. 1995. Sum and glucocorticoids affect the expression of brain-derived neurotrophic factor and neuro-trophin-3 mRNAs in the hippocampus. J Neurosci 15:1768-1777.
62. Stahl SM. 1998. Basic psychopharmacology of antidepressants, Part 1: Antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 59 (Suppl 4):5-14.
63. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. 1987. Bilirubin is an antioxidant of possible physiological importance. Science 235:1043-1046.
64. Stout SC, Owens MJ, Nemeroff CB. 2002. Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. J Pharmacol Exp Ther 300:1085-1092.
65. Tanapat P, Hastings NB, Rydel TA, Galea LA. Gould E. 2001. Exposure to fox odor inhibits cell proliferation in the hippocampus of adult rats via an adrenal hormone-dependent mechanism. J Comp Neurol 437:496-504.
66. Tatsumi M, Jansen K, Blakely RD, Richelson E. 1999. Pharmacological profile of neuroleptics at human monoamine transporters. Eur J Pharmacol 368:277-283.
67. Vaidya VA, Marek GJ, Aghajanian GK, Duman RS. 1997. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 17:2785-2795.
68. van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD, Gage FH. 2002. Functional neurogenesis in the adult hippocampus. Nature 415: 1030-1034.
69. Wakade CG, Mahadik SP, Waller JL, Chiu FC. 2002. Atypical neuroleptics stimulate neurogenesis in adult rat brain. J Neurosci Res 69: 72-79.
70. Watanabe Y, Gould E, McEwen BS. 1992. Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res 588:341-345.
71. Weber CM, Eke BC, Maines MD. 1994. Corticosterone regulates heme oxygenase-2 and NO synthase transcription and protein expression in rat brain. J Neurochem 63:953-962.
72. Weiss AP, Dewitt I, Goff D, Ditman T, Heckers S. 2005. Anterior and posterior hippocampal volumes in schizophrenia. Schizophr Res 73:103-112.
73. Wetmore C, Ernfors P, Persson H, Olson L. 1990. Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp Neurol 109:141-152.
74. Wetmore C, Olson L, Bean AJ. 1994. Regulation of brain-derived neurotrophic factor (BDNF) expression and release from hippocampal neurons is mediated by non-NMDA type glutamate receptors. J Neurosci 14:1688-1700.
75. Xu H, Qing H, Lu W, Keegan D, Richardson JS, Chlan-Fourney J, Li XM. 2002. Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett 321:65-68.
76. Xu H, Richardson JS, Li XM. 2003. Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 28:53-62.
77. Xu H, Luo C, Richardson JS, Li XM. 2004. Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine. Pharmacogenomics J 4:322-331.
78. Zhang XY, Zhou DF, Cao LY, Wu GY, Shen YC. 2005. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: Association with psychopathology and response to antipsychotics. Neuropsychopharmacology 30:1532-1538.